ABSTRACT. The role of extracellular Ca++ in the development of biphasic insulin release has been studied previously by using Verapamil to block the glucose-induced stimulation of Ca++ uptake. It was found that glucose-stimulated uptake of ca++ from the extracellular fluid was important for the second phase of insulin release but had no role in the first phase. In the current study, the role of intracellular ca++ stores in biphasic insulin release has been studied.
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Isolated rat islets were maintained in tissue culture for 46 h with normal (1 mM) or high (5 mM) phosphate concentrations. The intracellular calcium content of islets maintained in high phosphate was 50 times greater than the content of control islets. Insulin release was studied by perifusion, and the Ca ++ concentration in the medium was decreased to 0.1 mM during stimulation with high glucose to minimize the effect of extracellular S TIMULATION of insulin release from the B cells of islets of Langerhans by a rapid increase in glucose concentration is characterized by a two-phase response (1) (2) (3) (4) . Characteristically, a rapid peak of release (first phase) is followed by a period of slowly increasing release (second phase). The mechanism responsible for this biphasicity has not been elucidated. It has been suggested that the first phase is due to 1) a small labile pool of insulin-containing granules distinct from the majority of granules in that they are more susceptible to release, perhaps by their sensitivity to fusion with the plasma membrane or by close apposition to structures critical to the release process (5-7); 2) individual B cells that have differential sensitivity to glucose (8); 3) an initial burst of insulin release which then causes a transient feedback inhibition of subsequent release (9, 10); 4) effects such as the concomitant release of somatostatin (11) ; or 5) a biphasic change in the concentration of an intracellular mediator of release (12) . As Ca++ is known to be required for (13, 14) and can alone stimulate (15) (16) (17) (18) (19) (20) insulin release, a rise in intracellular Ca ++ concentration is now considered to be a major controlling influence in stimu-t To whom requests for reprints should be addressed.
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Ca++. The islets maintained in normal phosphate responded with a transient subnormal first phase insulin release. In contrast, 16.7 mM glucose elicited a 3.5-fold greater first phase release from the ca++_loaded islets. This release was quantitatively similar to the first phase response of islets perifused with 1 mM ca++ throughout. ca++ loading also increased the rate of second phase insulin release, but this was less marked than that observed for the first phase.
It is concluded that the handling of intracellular ca++ is primarily responsible for the first phase of insulin release, whereas both intracellular ca++ and increased uptake of ca++ from the extracellular compartment are involved in the genesis and development of the second phase. (Endocrinology 106: 1013, 1979) Ius-secretion coupling in B cells, as suggested previously for other secretory cells (21, 22 ). Thus, it seems possible that the biphasic insulin release is a reflection of a biphasic change in the concentration of cytosol Ca++ (23) . In considering this possibility, it has been demonstrated that the effect of high glucose to increase the uptake of extracellular ca++ by islets (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) is necessary for second phase release but plays no part in the first phase response (23) . If increased cytosol Ca++ is required for insulin release, it follows that intracellular Ca ++ must play the major role in the genesis of first phase release. To investigate the role of intracellular Ca ++ stores in biphasic release of insulin, the responses to glucose by islets that have had their intracellular stores loaded with ca++ have been compared with those of islets containing normal Ca ++ stores.
Materials and Methods

Isolation and
45 Ca ++ loading of the islets Pancreatic islets were isolated by the collagenase digestion technique (34) (29) . In parallel determinations, the extracellular space was 1.1 ± 0.11 nl/islet (n = 19) for islets maintained at 1 mM phosphate and 2.1 ± 0.25 (n = 18) for islets maintained at 5 mM phosphate. As the islets were in isotopic equilibrium with the medium 45 Ca++, the calcium content was expressed as picomoles per islet by calculation from the specific activity of 45 Ca++ in the medium (37) .
Perifusion of the islets and measurement of insulin release
The islets were perifused using 40 islets/chamber, as described in detail previously (4, 29, 37) . The perifusate consisted of Krebs-Ringer bicarbonate buffer (KRB) containing 1.0 mM CaCh (except when stated), 0.5% dialyzed bovine serum albumin, and 2.8 mM glucose. Phosphate concentrations were either 1.0 mM (normal KRB buffer) or 5 mM (high phosphate KRB buffer). The phosphate salt used was KH2P04, and the concentration of KCl in the high phosphate KRB was reduced to maintain a constant final concentration ofK+ and isoosmolarity. The islets, after calcium loading, were placed directly in the perifusion chamber without washing. From zero time to 46 min, the islets were perifused with the appropriate normal or high phosphate KRB buffer containing 2.8 mM glucose. Unless otherwise stated, the islets were then exposed to 16.7 mM glucose, and the stimulation period was continued for another 44 min.
The chamber volume was 70 j.Ll, and the flow rate was 1.2 ml/ min. Changes in CaCh concentration are detailed in the text. An aliquot of each sample was assayed for immunoreactive insulin by the method of Herbert et al. (38) using rat insulin as standard.
Measurement of islet insulin and glucagon content
Batches of 10 islets were placed in 1 ml acid ethanol (750: 235:15, vol/vol, ethanol-water-concentrated HCl) and left overnight at 4 C. The supernatants were then assayed at appropriate dilutions for immunoreactive insulin and immunoreactive glucagon. Immunoreactive glucagon was measured by the method of Unger et al. (39) using pork glucagon as standard and rabbit antipork serum (serum 30K).
Materials used
All materials used were as described previously (23), except for pork glucagon used as a standard for immunoassay which was obtained from Novo Research Institute (Bagsvaerd, Denmark) and glucagon antiserum 30K (obtained from Dr. R. H . Unger, University of Texas Southwestern Medical School, Dallas, TX).
Statistics
Analyses were performed with Student's t test for unpaired data, except when stated otherwise. Values are expressed as the mean± SEM.
Results
Islet Ca content
The time course of 45 Ca accumulation in islets maintained in the presence of 1 or 5 mM phosphate was studied. Total exchangeable calcium was measured 1, 4, 24, 48, and 72 h after the addition of 45 Ca ++. In islets maintained in 1 mM phosphate (controls), the 45 Ca content attained its maximum at 4 h, suggesting that the 45 Ca in the islets was in equilibrium with the isotope in the medium. The 45 Ca content was taken to represent total Ca content and was 13.2 ± 2.2 pmol/islet (n = 8) at 4 h. The 45 Ca content of islets maintained at 5 mM phosphate was 100 ± 20% of paired control islets at 1 h, 105 ± 18% at 4 h, 380 ± 46% at 24 h, 1908 ± 38 at 48 h, and 9560 ± 1338% at 72 h (n = 6-8). Although definite documentation of equilibration has to await measurement of tissue specific activity, the results suggest that the high phosphate concentration does not change the time of equilibration (4 h) with the isotope. However, the high phosphate concentration markedly increased the Ca content beyond 4 h, and the net gain of Ca had not even reached its maximum at 48 h. The time course of Ca accumulation was similar when the phosphate concentration in the medium was increased from 1 to 5 mM 24 h after the addition of 45 Ca++, at which time the accumulation of 45 Ca in the islets had attained its plateau. In a large series of experiments, the Ca content of islets maintained for 46 h in 1 mM phosphate was 11.4 ± 1.0 pmol/islet (n = 31) and 547 ± 65 pmol/islet (n = 28) in islets maintained in 5 mM phosphate. Thus, the intracellular Ca content was increased approximately 50-fold.
Insulin release
Both sets of islets were examined for insulin release under basal conditions (2.8 mM glucose) and during stim-ulation with high glucose (16.7 mM). Two series of experiments were performed, and basal insulin release was assessed by estimating the mean insulin release between 41-46 min. The mean values for the first series ( Fig. 1 ) were 7.2 ± 0.8 pg/islet· min (n =-17) and 5.9 ± 0.6 (n = 16; P > 0.20) for islets maintained at 1 and 5 mM phosphate, respectively; in the second series (Fig. 2) , the values were 9.8 ± 0.9 (n = 20) and 7. 7 ± 0.6 (n = 21; P > 0.05). For the study of glucose-stimulated release, in the first series of experiments, the conditions were chosen so that the effect of extracellular ca++ was minimized at the time that the high glucose stimulus was applied. To achieve this, the extracellular Ca ++ concentration was reduced to 0.1 mM as the glucose concentration was increased to 16.7 mM (these results are shown in Fig. 1 ). Under these conditions, insulin release is usually much reduced. Islets maintained in 5 mM phosphate were perifused with 2.8 mM glucose, 1.0 mM ca++, and 5 mM phosphate to maintain high ca++ loading. At 46 min, the composition of the perifusate was changed to 16.7 mM glucose and 0.1 mM ca++, leaving the 5 mM phosphate unchanged. Islets maintained in normal phosphate were switched similarly at 46 min to 16.7 mM glucose and 0.1 mM Ca ++, while leaving phosphate unchanged at 1.0 mM. In a second series of experiments, the medium Ca ++ concentration was kept at 1.0 mM throughout the experiment (these results are shown in Fig. 2) .
With low Ca++ (0.1 IDM) in the medium, the response of islets maintained under normal conditions and with normal stores of Ca ++ was characterized, as expected, by very small first and second phases of release. The time course of the first phase response was normal and was complete by the 53rd minute, a time which is at the nadir between the first and second phases in the normal controls (Fig. 2) . The response of islets maintained in high phosphate and with high levels of intracellular Ca ++ is in Endo • 1979 Vol105 • No4 marked contrast to normally maintained islets. Despite the perifusate ca++ concentration of 0.1 mM, glucose induced a prompt and very large surge of insulin release. The first phase response reached peak rates of release of 79 pg/islet. min. This may be compared with the peak rate of normally maintained islets, which was 25 pg/islet· min. The decline in the insulin release rate from the loaded islets then appeared to have a normal time course. The difference between the first phase insulin release by ca++_loaded islets and that by normal islets was determined ( Table 1) by integration of the insulin release above baseline for each individual perifusion chamber between min 47-51, a period of time which best quantitates the first phase with minimal interference (overlap) by the second phase. The ca++_loaded islets released 185 pg insulin/islet, in contrast to 53 pg by the normal islets. Thus, the ca++_loaded islets released 3.5 times more during the first phase than the normal islets. Furthermore, comparison with Fig. 2 shows that the Ca ++-loaded islets released as much insulin during the first phase in the face of 0.1 mM ca++ in the medium as did normal islets in the presence of 1.0 mM Ca ++.
Second phase insulin release was reduced in both normal and loaded islets by the presence of 0.1 mM ca++ in the medium (Figs. 1 and 2 ), although the loaded islets were secreting insulin at a higher rate than the normal islets ( Fig. 1 and Table 1 ). Interestingly, in both situations (i.e. with normal and ca++_loaded islets), the second phase release was constant from the end of the first phase to the end of the observation period. Thus, no slowly rising second phase was detected in the presence of 0.1 mM ca++ as is usually the case in the presence of 1.0 mM ca++.
When the responses of the normal and ca++_loaded islets were compared in the presence of the usuall.O mM Ca ++ in the medium, no significant differences were detected. First and second phases followed similar courses. This suggests that the Ca ++-loading procedure has not impaired the integrity of the islets, as does the similarity of islet contents of insulin and glucagon (see results in Table 2 ).
Two series of control experiments were performed. In the first, the possibility that 5 mM phosphate acutely enhances glucose-induced insulin release was considered. Islets maintained under normal phosphate conditions were perifused in normal KRB buffer up to the min 46. At this time, one group of islets was exposed to a medium containing 16 .7 mM glucose, 0.1 mM ca++, and 5 mM phosphate, and another group was exposed to 16.7 mM glucose and 0.1 mM ca++ with normal phosphate maintained. First phase insulin release was similar in the two groups. In normal phosphate, the release was 32 ± 3 pg insulin/islet, and in 5 mM phosphate, the release was 31 ± 6 pg insulin/islet (P = 0.8; n = 4). Therefore, the presence of a high phosphate concentration per se under " these conditions had no influence on glucose-induced release. The second control series investigated the possibility that in islets maintained for 46 h in 5 mM phosphate, the change in perifusate concentration from 1.0 to 0.1 mM ca++ was responsible for the large stimulation of insulin release rather than the increased glucose concentration. Therefore, islets maintained under high' and normal phosphate conditions were perifused in high and normal phosphate KRB buffer, respectively, throughout the experiments. After 46 min, both sets of islets were changed from 1.0 to 0.1 mM ca++ but with no change in the 2.8 mM glucose concentration. The change in Ca ++ caused only a small and transient insulin release. In the normal islets, total incremental insulin release above baseline was 8 ± 4 pg/islet during min [47] [48] [49] [50] [51] (n = 18), 43 ± 2 (20)" 5 ± 1 (13) Results are expressed as nanograms per islet(± SEM). The number of determinations is shown in parentheses.
"P> 0.20.
while the Ca ++-loaded islets released 12 ± 3 pg/islet during min 47-51 (n = 10); the release rates were not significantly different (P > 0.3). After 51 min, the release from both sets of islets returned to the basal rates seen before the switch in Ca ++ concentration. These results were not changed by the addition of 13.9 mM L-glucose at 46 min (data not shown).
Discussion
The in vitro maintenance of isolated pancreatic islets permits prolonged exposure of the islets to various conditions. The dramatic increase of total exchangeable calcium in the islets after maintenance for 2 days in the presence of 5 mM phosphate had no adverse effect on their content or release of insulin. Neither basal nor glucose-stimulated insulin release from islets maintained and perifused at high (5 mM) phosphate concentrations differed significantly from those of control islets when the perifusate Ca ++ was 1 mM. Since, in addition, insulin content of the two types was similar, it is unlikely that high phosphate concentrations induce changes in insulin biosynthesis or glucose recognition by the islets. Furthermore, the addition of 5 mM phosphate only during glucose stimulation did not alter the insulin release. This appears to be at variance with the results of Hellman and Andersson, who reported that 10 mM phosphate inhibit glucose-induced insulin release from freshly isolated ob/ ob mouse islets (40) when added together with the stimulus. These authors also reported that high phosphate concentrations stimulate the uptake of 45 Ca++ (40). Two effects of glucose on the net movement of Ca across the plasma membrane have been documented in islets of Langerhans which are thought to be related to the stimulation of insulin release. These are: 1) inhibition of ca++ efflux (37, (41) (42) (43) and 2) increased ca++ uptake (23) (24) (25) (26) (27) (28) (29) (30) . A major role for the precise control of cytosol Ca ++ has been given to the membranes of intracellular organelles which store Ca because, despite a lack of knowledge of flux rate constants in intact cells, the intracellular storage capacity is large, calcium uptake mechanisms have been demonstrated (44) (45) (46) , and the surface area of intracellular membranes is large relative to the surface area of the plasma membrane. In seeking an explanation for the biphasic nature of glucose-induced insulin release, the possibility has been considered that the interplay of the effects of glucose on intracellular and extracellular Ca handling is responsible for a biphasic change in the cytosol ca++ concentration which, in turn, determines the biphasic pattern of release. As a first step, the role of extracellular Ca and glucose-stimulated uptake of 45 Ca++ was studied. It was found that by the use of Verapamil, an agent known to block Ca ++ channels, glucose-stimulated 45 Ca++ uptake could be completely blocked without any significant effect on the first phase of insulin release (23) . Therefore, glucose-stimulated Ca uptake plays no role in the first phase of release. As a consequence, if an increase of cytosol Ca ++ is required for insulin release, then utilization of intracellular Ca ++ must be involved in the causation of first phase release. Evidence in favor of this conclusion can be seen in the paper by Lundquist et al. (47) in which an experimental protocol similar to that used in this study was applied, i.e. when the isolated perfused pancreas was subjected to a change from low glucose and normal Ca ++ to high glucose and zero Ca ++. In this situation, a first phase response was primarily observed. Similarly, experiments by Henquin (48) involving exposure of islets to high glucose and approximately 20 p.M Ca ++ resulted in almost complete suppression of the second phase but only 50% inhibition of the first phase. As the first and second phases were not clearly distinct in these experiments, some of the 50% inhibition observed during the first phase could be ascribed to inhibition of the overlapping second phase component (23) . Thus, the first phase shows considerable resistance to decreased extracellular Ca ++ concentrations, as would be expected if it were largely dependent upon intracellular Ca++. However, on the basis of experiments with theophylline in the presence of 20 p.M Ca ++ in which an apparent second, but not first, phase response was resto~ed, Henquin concluded that the second phase response was more dependent upon intracellular Ca ++ than the first phase one. This conclusion is based on the assumption that theophylline mobilizes intracellular Ca ++, and we are unable to reconcile it with our own data.
In the present study, both phases of glucose-induced insulin release in control islets were reduced in the presence of low extracellular Ca ++, albeit the first phase less than the second phase (Table 1) . This difference between the two phases was best seen in islets which had their intracellular Ca ++ stores loaded. When perifused in the presence of low ca++, the rates of insulin release during the first phase were elevated to values similar to those seen at normal extracellular ca++. However, the release rates during the second phase, while being higher than those seen in control islets at low Ca ++, failed to reach the rates observed at normal ca++ (50% reduction). It Endo • 1979 Vol lOS • No4 appears, therefore, that intracellular ea++ stores are involved in the control of both phases of insulin release, but that their role is particularly important for the full development of the first phase. This agrees with our previous data that Verapamil blockade of glucose-stimulated calcium uptake did not inhibit first phase release but inhibited second phase insulin release by 55%. The combined data suggest strongly that the first phase response to glucose is generated by utilization of intracellular ea++ and the second phase requires both intracellular ea ++ and increased uptake of extracellular ea ++ for its full development. The reason glucose did not elicit a higher insulin release from the islets with increased ea stores at 1 mM ea++ is unclear. It may be that insulin release in response to 16.7 mM glucose in normal islets perifused at 1 mM ea ++ is already maximal and cannot be further augmented by increased ea stores. This is supported by our earlier observations that insulin release in response to 16.7 mM glucose was not further enhanced at 10 mM extracellular ea++ (37), a ea++ concentration which by itself stimulates insulin release (16) .
When assessing the effects of glucose on cytosolic ea ++ concentrations, it has been proposed that •sea ++ efflux from preloaded islets may reflect the cytosolic ea ++ concentration. This view is supported by the fact that glucose-stimulated insulin release can be completely inhibited without major changes in glucose-stimUlated •sea++ efflux (29, 37, 40, 49) . This makes it unlikely that •sea++ is released together with the secretory granule content during exocytosis. It is therefore of particular interest that a biphasic 4 sea ++ efflux pattern is associated with the biphasic insulin release when two distinct phases are observed, as is the case in this and an earlier study (23) in islets maintained for 2 days in the presence of •sea++. Based on these considerations and the results from the previous (23) and present studies, a model for biphasic insulin release is proposed. The initial inhibitory effect of glucose on ea++ efflux across the plasma membrane and a possible inhibition of intracellular ea++ sequestration by glucose or its metabolites (46) would both contribute to raise cytosolic ea++. It appears that cytosolic ea ++ rises to high values and is then pumped down by an increased activity of the ea ++-extruding mechanism in the plasma membrane seen as a spike in •sea++ efflux (23, 37, 49) and possibly by intracellular storage mechanisms as these try to adjust to a new equilibrium position. This overshoot phenomenon would determine the first phase insulin response. The new equilibrium position is thought to be reached at the nadir between the two phases of insulin release. This is indicated by the constant insulin release rate during the second phase when the influence of extracellular ea ++ was minimized by perifusing both normal and ea ++-loaded islets at 0.1 mM ea++ (Fig. 1) . Similarly, when glucose-stimulated ea ++ uptake was inhibited by Verapamil, second phase insulin release was reduced to a simple plateau (23) . Indeed, under these conditions, glucose-stimulated 45 ea ++ efflux does not show a secondary rise during the second phase but, after the first phase spike, remains parallel with basal 45 ea++ efflux (23) . The 45 ea ++ efflux and insulin release pattern thus support the concept of a new equilibrium in ea++ fluxes reached at the nadir when the effects of extracellular ea ++ are reduced. The rising portion of the second phase insulin release seen at normal extracellular ea ++ could be due to a gradually increasing cytosolic ea++ concentration, as a gradual net gain of ea ++results from the glucose-induced imbalance of plasma membrane fluxes.
